Current Proteomics

Current Proteomics is a review journal in the proteomics field, founded in 2004 and now issued from volume 22 onward on ScienceDirect, with publishing services by Elsevier on behalf of KeAi Communications.《当前蛋白质组学》是蛋白质组学领域的一份综述期刊，创刊于 2004 年，自第 22 卷起在 ScienceDirect 上发行，出版事务由 Elsevier 代 KeAi Communications 承办。

The principal purpose is to publish in-depth reviews and short reviews on developments that matter to the direction of proteomics research, and the volumes before the move remain readable on the former platform.该刊的主要宗旨是发表紧扣蛋白质组学研究走向的深入综述与短综述，移交之前的各卷仍可在原平台阅读。

In the 2025 edition of the journal citation report the title carries an impact factor of 1.3 and is placed in the fourth quartile of both of its subject categories.在 2025 年版期刊引证报告中，该刊的影响因子为 1.3，在两个主题类目中均列第四区。

Scope

• Coverage extends across the whole of proteomics together with the methodology, the software, the databases and the technological advances that the field has produced, functional proteomics included.刊载内容覆盖蛋白质组学的全部领域，以及这一学科积累的方法、软件与数据库，也涵盖功能蛋白质组学方面的技术进展。

• The techniques singled out by the editors include two-dimensional gel electrophoresis with image analysis, the analysis of protein complexes and biomolecular interaction analysis.编辑特别点名的技术包括二维凝胶电泳与图像分析，蛋白质复合物分析与生物分子相互作用分析亦在其列。

• The determination of co-translational and post-translational modification of proteins is covered, including the question of where a given modification sits along the chain.蛋白质共翻译与翻译后修饰的鉴定也在覆盖之列，包括某一种修饰落在肽链哪一段这一问题。

• High-throughput computational methods for the three-dimensional structure and the function of proteins make up another named area of the subject.用于解析蛋白质三维结构与功能的高通量计算方法，构成又一处被点名的选题领域。

• Structural studies are expected to draw on mass spectrometry, nuclear magnetic resonance and X-ray crystallography, all three being written into the statement of aims.结构层面的研究要求借助质谱、核磁共振与 X 射线晶体学，这三样都写进了宗旨说明。

• Tools for the integration and management of knowledge, techniques for the separation and characterisation of proteins and protein or peptide microarrays are admitted as well.用于知识整合与管理的工具，蛋白质分离与表征技术，以及蛋白质与多肽微阵列，同样在可刊之列。

• Protein interaction pathways and the signalling networks of the cell belong to the subject, and proteome informatics is named together with robotics, nanotechnology and microfluidics.蛋白质相互作用通路与细胞信号网络属于选题范围，蛋白质组信息学则与机器人技术、纳米技术及微流控并列为名。

• Systems biology is carried on the same list, along with techniques for protein expression profiling, the mass spectrometry based methods and the algorithms that correlate a spectrum with a database, and yeast two-hybrid projects are named in the same passage.系统生物学在同一份名单之列，与蛋白质表达谱技术、基于质谱的方法以及把谱图与数据库对应的算法并列，酵母双杂交项目也在同一段文字里被提到。

• A separate section is kept for product and technology reports, and the proceedings of proteomics meetings appear with selected review articles drawn from them.期刊另设一节用于产品与技术报告，会议论文集则以从中选出的综述文章形式出现。

• The subject is divided into four sections, the first on protein and protein modification research, the second on drug proteomics, the third on molecular and cellular proteomics and the fourth on clinical proteomics.选题被划为四个板块，第一个处理蛋白质与蛋白质修饰研究，第二个是药物蛋白质组学，第三个针对分子与细胞蛋白质组学，第四个面向临床蛋白质组学。

• The first section takes in protein expression profiling, complex structural work and post-translational modifications such as ubiquitination, phosphorylation, glycosylation, nitrosylation, acetylation and lipidation.第一个板块涵盖蛋白质表达谱与复合物结构工作。泛素化、磷酸化与糖基化等修饰都归于此处，亚硝基化、乙酰化和脂化同样在列。

• Newer acylations are introduced there, among them succinylation, crotonylation, two-hydroxyisobutyrylation and lactylation, and the combined analysis of proteomics with multi-genomics is covered.该板块还引入了较新的酰化修饰，琥珀酰化、巴豆酰化与羟基异丁酰化见于其中，乳酰化与蛋白质组结合多基因组学的分析同样得到处理。

• Drug proteomics is the second section and takes up the interaction of drugs with proteins, the identification of targets, mechanisms of action and the assessment of efficacy.第二个板块是药物蛋白质组学。药物与蛋白质的相互作用、靶点鉴定与作用机制都在此列，疗效评估同样被纳入。

• The third section covers the integration of protein omics with other omics in basic and applied work, proteogenomics, pathway analysis, the dynamics and quality control of the proteome, chemical proteomics, the immune system and the microbiome.第三个板块处理蛋白质组学与其他组学在基础与应用研究中的整合。蛋白质基因组学与通路分析列于此处，蛋白质组动态与质量控制同样在列，化学蛋白质组学与免疫系统、微生物组的研究也被涵盖。

• The fourth section is clinical proteomics, which takes in translational work, the use of proteomic techniques in clinical research and molecular medicine, and the study of modification proteomics.第四个板块是临床蛋白质组学。转化层面的工作与蛋白质组技术在临床研究及分子医学中的运用归于此处，修饰蛋白质组学也是其研究对象。

History

• The first issue appeared in January 2004 as volume 1 number 1, and the numbering of the volumes follows the calendar, so that volume 17 falls in 2020 and volume 22 in 2025.首期于 2004 年 1 月出版，为第 1 卷第 1 期。卷号与年份对应，第 17 卷落在 2020 年，第 22 卷落在 2025 年。

• The title was founded by Bentham Science Publishers, whose imprint named Saif Zone in Sharjah together with San Francisco in California, and articles of that period are deposited under the prefix 10.2174.该刊由 Bentham Science Publishers 创办，早期出版信息上写的是阿联酋沙迦的 Saif Zone 与加利福尼亚的旧金山，那个时期的论文以 10.2174 前缀存档。

• Through volume 12 in 2015 the journal appeared four times a year, the arrangement that the national medical library still records as quarterly.到 2015 年的第 12 卷为止，该刊每年出四期，这正是美国国立医学图书馆至今记作季刊的形制。

• Five issues a year set in from volume 15 in 2018, and from volume 22 in 2025 the count reached six, which is the form the title keeps today.自 2018 年的第 15 卷起变为每年五期，自 2025 年的第 22 卷起增到六期，这便是该刊目前保持的形制。

• The platform states that everything before volume 22 is still held by the former address of the old publisher, and from that volume the articles carry a different identifier, the prefix 10.1016 followed by the short stem of the title.平台说明写道，第 22 卷之前的内容仍存放在原出版方的旧址，自该卷起论文换用另一套标识符，前缀 10.1016 之后接该刊的短名。

• The copyright line reads that publishing services are by Elsevier on behalf of KeAi Communications, and the owner keeps the copyright of the compiled volumes.版权行写明出版事务由 Elsevier 代 KeAi Communications 承办，期刊所有者保留整卷的版权。

• The catalogue of the national medical library carries the older imprint from 2004 and a current one that names Elsevier in New York from 2025.美国国立医学图书馆的目录同时记有 2004 年的旧出版信息与现行的一条，后者写的是 2025 年起在纽约由 Elsevier 出版。

• The print number is 1570-1646 and the electronic number is 1875-6247, the short form of the title in the medical catalogue being Curr Proteomics.印刷版编号为 1570-1646，电子版编号为 1875-6247，医学目录中该刊的简称是 Curr Proteomics。

• In the medical catalogue the title is indexed under PubMed for selected citations only, and the single subject heading applied to it is proteomics.在医学目录中，该刊的 PubMed 收录标注为仅选录部分引文，所用的唯一主题词是蛋白质组学。

• The platform lists its abstracting services, Chemical Abstracts and Embase among them, then Scopus, ProQuest and EBSCOhost, together with the expanded citation index and Essential Science Indicators.平台列出其文摘与索引服务，Chemical Abstracts 与 Embase 列在其中，Scopus、ProQuest 和 EBSCOhost 亦然，扩展版引文索引与 Essential Science Indicators 同在其中。

• Under the old publisher the journal was sold on subscription with open access offered as an option, and from the move onward every article has been free to read at once under a Creative Commons licence, with no charge listed on the platform.在原出版方手里，该刊以订阅制销售，开放获取只是可选选项；自移交之后，每篇文章都可立即免费阅读，采用 Creative Commons 许可协议，平台列出的费用为零。

• In the 2025 citation report the journal sits in the fourth quartile of the two categories that cover it, with 228 citations and 31 articles in the year.在 2025 年版引证报告中，该刊在覆盖自身的两个类目中均列第四区，全年被引 228 次，载文 31 篇。

• The indicator itself has moved from 0.837 in 2021 to 0.642 in 2022 and 0.5 in both 2023 and 2024, before rising to 1.3 in 2025.该指标从 2021 年的 0.837 降到 2022 年的 0.642，2023 与 2024 年均为 0.5，2025 年回升到 1.3。

Editors

• The editor-in-chief is Shibiao Wan, who works at the University of Nebraska Medical Center in Omaha.主编是（Shibiao Wan），任职于内布拉斯加大学医学中心（Omaha）。

• Three co-editors-in-chief share the load, Hao Lin of the University of Electronic Science and Technology of China in Chengdu, Qingliang Meng of the Henan Province Hospital of TCM in Zhengzhou, and Ming Xia of the pain medicine department at the Yangpu Hospital affiliated to Tongji University in Shanghai.另有三位共同主编分担其事，分别是电子科技大学的（Hao Lin）、河南省中医院的（Qingliang Meng）与上海同济大学附属杨浦医院疼痛科的（Ming Xia）。

• Above the co-editors sit a current frontiers editor, Manoj K. Kashyap of Amity University Haryana, and an honorary senior advisor, Ajoy Basak of the University of Ottawa, a name that was profiled as editor-in-chief back in 2015.共同主编之上还设一位当期前沿编辑（Current Frontiers Editors），来自 Amity University Haryana 的（Manoj K. Kashyap），另设荣誉资深顾问一职，由渥太华大学的（Ajoy Basak）担任，2015 年该刊曾以主编身份介绍过这位学者。^[1]

• A section editor handles the special issues, Zuo-Fei Yuan of the St. Jude Children's Research Hospital in Tennessee.专刊事务由一位板块编辑负责，是田纳西州圣裘德儿童研究医院的（Zuo-Fei Yuan）。

• Three associate editors support the main team, Seval Yilmaz of Firat University, Song Dingyun of the Chinese PLA General Hospital in Beijing, and Heng Li of the People's Hospital affiliated to Chongqing University.三位副编辑襄助主编，分别是 Firat University 的（Seval Yilmaz）、中国人民解放军总医院的（Song Dingyun）与重庆大学附属人民医院的（Heng Li）。

• Twelve more names are listed as associate editorial board members drawn from universities and hospitals in several countries.另有十二人列为编委成员，分属多所高校与医院。大连医科大学、辛辛那提大学医学院与天津大学都在其列，马来西亚理科大学与温州医科大学同样在列。

• The editorial advisory board runs to some sixty names, drawn from Italy, Switzerland, Australia, South Korea, Austria, Singapore, Pakistan, the United Arab Emirates, the United States and China.顾问编委的名册约有六十人，分布在多个国家。意大利、瑞士与澳大利亚占了相当一部分，韩国的机构与奥地利、新加坡的学者也有代表，美国与中国的成员数量同样可观。

• The editorial signed in 2009 belongs to Humberto Gonzalez-Diaz, and the ones in 2011 and 2012 were written by Yehia Mechref and Bernd Rehm in turn.2009 年那篇社论出自（Humberto Gonzalez-Diaz），2011 与 2012 年的社论则先后由（Yehia Mechref）与（Bernd Rehm）撰写。^[2]

• Guest editors were drawn in for themed numbers, Qing-Yu He for a special issue on post-translational proteomics in 2010, Francisco Javier Fernandez-Acero for plant microbe interactions, and Wadie F. Bahou for platelet proteomics in 2011.专刊常由客座主编领衔，2010 年的翻译后修饰蛋白质组学专刊由（Qing-Yu He）主编，植物与微生物相互作用的专题由（Francisco Javier Fernandez-Acero）负责，2011 年的血小板蛋白质组学专题则出自（Wadie F. Bahou）。^[3]

• A column introduced one of the section editors in 2020, written by Lei Chen, and an earlier themed issue of 2018 had dealt with computational methods for biomedicine.2020 年该刊设有介绍板块编辑的专栏，由（Lei Chen）撰写，2018 年更早的一个专题曾讨论面向生物医学的计算方法。

• The peer review at the title is double anonymized, a manuscript is screened by the editorial office first and then sent to at least two independent reviewers, and papers that miss the basic standard of the journal are turned down at the desk for reasons of scope, ethics or overlap.该刊实行双盲评审，稿件先由编辑部筛查，再送交至少两位独立审稿人，达不到期刊基本标准的稿件则因选题、伦理或重复度问题被编辑部直接退稿。

• A paper from a board member with a conflict of interest is passed to a different team member, and the same arrangement covers a guest editor of a special issue.来自与编辑存在利益冲突的编委成员的稿件会交给另一位成员处理，专刊客座主编涉及利益冲突时同样如此。

• Manuscripts are handled in an online system, decisions arrive by email, and authors keep the copyright of the single article while the owner is granted non-exclusive publishing and distribution rights.稿件在在线系统中处理，决定以邮件送达，作者保留单篇论文的版权，期刊所有者则获授非独占的出版与发行权。

• The types of paper carry stated limits, with research articles running to seven thousand words, reviews to ten thousand, short communications to fifteen hundred and editorials to two thousand.各类论文设有字数上限，研究论文可到七千字，综述可到一万字，短篇通讯为一千五百字，社论为两千字。